Cargando…

25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype

CONTEXT: There is uncertainty over the equivalence of vitamins D(2) and D(3) to maintain plasma 25-hydroxyvitamin D (25(OH)D). OBJECTIVE: The objective of the study was to compare the plasma half-lives of 25(OH)D(2) and 25(OH)D(3) in two distinct populations with different dietary calcium intake and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, K. S., Assar, S., Harnpanich, D., Bouillon, R., Lambrechts, D., Prentice, A., Schoenmakers, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207933/
https://www.ncbi.nlm.nih.gov/pubmed/24885631
http://dx.doi.org/10.1210/jc.2014-1714
_version_ 1782341057363574784
author Jones, K. S.
Assar, S.
Harnpanich, D.
Bouillon, R.
Lambrechts, D.
Prentice, A.
Schoenmakers, I.
author_facet Jones, K. S.
Assar, S.
Harnpanich, D.
Bouillon, R.
Lambrechts, D.
Prentice, A.
Schoenmakers, I.
author_sort Jones, K. S.
collection PubMed
description CONTEXT: There is uncertainty over the equivalence of vitamins D(2) and D(3) to maintain plasma 25-hydroxyvitamin D (25(OH)D). OBJECTIVE: The objective of the study was to compare the plasma half-lives of 25(OH)D(2) and 25(OH)D(3) in two distinct populations with different dietary calcium intake and 25(OH)D status. PARTICIPANTS: Healthy men (aged 24 and 39 y), resident in The Gambia (n = 18) or the United Kingdom (n = 18) participated in the study. INTERVENTIONS: The intervention included an oral tracer dose of deuterated-25(OH)D(2) and deuterated-25(OH)D(3) (both 40 nmol). Blood samples were collected over 33 days. MAIN OUTCOME MEASURES: 25(OH)D(2) and 25(OH)D(3) plasma half-lives, concentrations of 25(OH)D, and vitamin D binding protein (DBP) and DBP genotypes were measured. RESULTS: 25(OH)D(2) half-life [mean (SD)] [13.9 (2.6) d] was shorter than 25(OH)D(3) half-life [15.1 (3.1) d; P = .001] for countries combined, and in Gambians [12.8 (2.3) d vs 14.7 (3.5) d; P < .001], but not in the United Kingdom [15.1 (2.4) d vs 15.6 (2.5) d; P = .3]. 25(OH)D concentration was 69 (13) and 29 (11) nmol/L (P < .0001), and the DBP concentration was 259 (33) and 269 (23) mg/L (P = .4) in The Gambia and United Kingdom, respectively. Half-lives were positively associated with plasma DBP concentration for countries combined [25(OH)D(2) half-life: regression coefficient (SE) 0.03 (0.01) d per 1 mg/L DBP, P = .03; 25(OH)D(3) half-life: 0.04 (0.02) d, P = .02] and in Gambians [25(OH)D(2) half-life: 0.04 (0.01) d; P = .02; 25(OH)D(3) half-life: 0.06 (0.02) d, P = .01] but not in UK participants. The DBP concentration × country interactions were not significant. DBP Gc1f/1f homozygotes had shorter 25(OH)D(2) half-lives compared with other combined genotypes (P = .007) after correction for country. CONCLUSIONS: 25(OH)D(2) half-life was shorter than 25(OH)D(3) half-life, and half-lives were affected by DBP concentration and genotype. The stable isotope 25(OH)D half-life measurements provide a novel tool to investigate vitamin D metabolism and vitamin D expenditure and aid in the assessment of vitamin D requirements.
format Online
Article
Text
id pubmed-4207933
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-42079332014-11-04 25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype Jones, K. S. Assar, S. Harnpanich, D. Bouillon, R. Lambrechts, D. Prentice, A. Schoenmakers, I. J Clin Endocrinol Metab Endocrine Research CONTEXT: There is uncertainty over the equivalence of vitamins D(2) and D(3) to maintain plasma 25-hydroxyvitamin D (25(OH)D). OBJECTIVE: The objective of the study was to compare the plasma half-lives of 25(OH)D(2) and 25(OH)D(3) in two distinct populations with different dietary calcium intake and 25(OH)D status. PARTICIPANTS: Healthy men (aged 24 and 39 y), resident in The Gambia (n = 18) or the United Kingdom (n = 18) participated in the study. INTERVENTIONS: The intervention included an oral tracer dose of deuterated-25(OH)D(2) and deuterated-25(OH)D(3) (both 40 nmol). Blood samples were collected over 33 days. MAIN OUTCOME MEASURES: 25(OH)D(2) and 25(OH)D(3) plasma half-lives, concentrations of 25(OH)D, and vitamin D binding protein (DBP) and DBP genotypes were measured. RESULTS: 25(OH)D(2) half-life [mean (SD)] [13.9 (2.6) d] was shorter than 25(OH)D(3) half-life [15.1 (3.1) d; P = .001] for countries combined, and in Gambians [12.8 (2.3) d vs 14.7 (3.5) d; P < .001], but not in the United Kingdom [15.1 (2.4) d vs 15.6 (2.5) d; P = .3]. 25(OH)D concentration was 69 (13) and 29 (11) nmol/L (P < .0001), and the DBP concentration was 259 (33) and 269 (23) mg/L (P = .4) in The Gambia and United Kingdom, respectively. Half-lives were positively associated with plasma DBP concentration for countries combined [25(OH)D(2) half-life: regression coefficient (SE) 0.03 (0.01) d per 1 mg/L DBP, P = .03; 25(OH)D(3) half-life: 0.04 (0.02) d, P = .02] and in Gambians [25(OH)D(2) half-life: 0.04 (0.01) d; P = .02; 25(OH)D(3) half-life: 0.06 (0.02) d, P = .01] but not in UK participants. The DBP concentration × country interactions were not significant. DBP Gc1f/1f homozygotes had shorter 25(OH)D(2) half-lives compared with other combined genotypes (P = .007) after correction for country. CONCLUSIONS: 25(OH)D(2) half-life was shorter than 25(OH)D(3) half-life, and half-lives were affected by DBP concentration and genotype. The stable isotope 25(OH)D half-life measurements provide a novel tool to investigate vitamin D metabolism and vitamin D expenditure and aid in the assessment of vitamin D requirements. Endocrine Society 2014-09 2014-06-02 /pmc/articles/PMC4207933/ /pubmed/24885631 http://dx.doi.org/10.1210/jc.2014-1714 Text en Copyright © 2014 by the Endocrine Society This article has been published under the terms of the Creative Commons Attribution License (CC-BY (http://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s). Author(s) grant(s) the Endocrine Society the exclusive right to publish the article and identify itself as the original publisher.
spellingShingle Endocrine Research
Jones, K. S.
Assar, S.
Harnpanich, D.
Bouillon, R.
Lambrechts, D.
Prentice, A.
Schoenmakers, I.
25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
title 25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
title_full 25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
title_fullStr 25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
title_full_unstemmed 25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
title_short 25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
title_sort 25(oh)d(2) half-life is shorter than 25(oh)d(3) half-life and is influenced by dbp concentration and genotype
topic Endocrine Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207933/
https://www.ncbi.nlm.nih.gov/pubmed/24885631
http://dx.doi.org/10.1210/jc.2014-1714
work_keys_str_mv AT jonesks 25ohd2halflifeisshorterthan25ohd3halflifeandisinfluencedbydbpconcentrationandgenotype
AT assars 25ohd2halflifeisshorterthan25ohd3halflifeandisinfluencedbydbpconcentrationandgenotype
AT harnpanichd 25ohd2halflifeisshorterthan25ohd3halflifeandisinfluencedbydbpconcentrationandgenotype
AT bouillonr 25ohd2halflifeisshorterthan25ohd3halflifeandisinfluencedbydbpconcentrationandgenotype
AT lambrechtsd 25ohd2halflifeisshorterthan25ohd3halflifeandisinfluencedbydbpconcentrationandgenotype
AT prenticea 25ohd2halflifeisshorterthan25ohd3halflifeandisinfluencedbydbpconcentrationandgenotype
AT schoenmakersi 25ohd2halflifeisshorterthan25ohd3halflifeandisinfluencedbydbpconcentrationandgenotype